Psychedelics Nirvana Life acquires exclusive license for novel psychedelic delivery system Canadian life sciences outfit continues to push the envelope in the clinical psychedelic sector Rowan DunneJuly 6, 2022
Psychedelics U.S. psychedelic drug market to reach $8.9B by 2029: DBMR report As rates of mental health disorders increase the demand for psychedelic treatments do too Rowan DunneJune 6, 2022
News More Canadians, Americans open to psychedelic therapy, surveys show Toronto-based Field Trip launched two new polls that show more people are open to using psychedelics to treat rising pandemic-related mental health issues Jared GnamMay 20, 2021
News FDA lifts ban on study of therapists taking MDMA After two years of dispute, MAPS is celebrating the decision Natalia Buendia CalvilloMay 14, 2021
News 67% of PTSD sufferers drop diagnosis in first MDMA Phase 3 trial Following the successful MAPS study, MDMA-assisted therapy moves closer to becoming approved by the US FDA Natalia Buendia CalvilloMay 4, 2021